Astaxanthin for Eye Strain and Screen Fatigue: What the Trials Actually Show
Educational summary — not medical advice. Astaxanthin is not a treatment or prevention strategy for macular degeneration, cataracts, or any eye disease; anyone with a diagnosed eye condition should see an ophthalmologist. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest answer
Real, but narrow and industry-funded. A 2023 trial (n=60, 9 mg/day, 6 weeks) found astaxanthin alone preserved corrected visual acuity after screen work — but only in adults 40 and older (Sekikawa 2023). A 2021 trial (n=44, combination formula, 6 weeks) found improved pupillary response and subjective focusing, but used astaxanthin combined with anthocyanin and lutein, so the individual contribution can't be isolated (Kizawa 2021). Both trials were industry-funded. Neither tested or supports any claim about eye disease.
Two trials, read carefully
The eye/screen-fatigue thread is the strongest evidence pocket for astaxanthin, but "strongest" here means "clearest signal in small trials" — not "settled." Both trials measured visual fatigue and function after sustained screen use in healthy adults, not disease outcomes, and both disclose limitations worth reading before you weigh the result.
| Study | Design | Dose & duration | Result |
|---|---|---|---|
| Sekikawa 2023 PMID 36777084 | RCT, n=60, astaxanthin alone | 9 mg/day, 6 weeks | Preserved corrected visual acuity after VDT work in the ≥40y subgroup only (p<0.05); no effect <40y |
| Kizawa 2021 PMID 34376917 | RCT, n=44, combination formula | Anthocyanin + astaxanthin + lutein, 6 weeks | Improved pupillary response + subjective focusing vs placebo |
Both industry-funded: Sekikawa 2023 was funded by BGG Japan. Neither trial is large by modern standards, and neither has been independently replicated by an unaffiliated research group at this dose and duration.
What "works" actually means here
Read precisely, the evidence supports a narrow claim: in a 6-week trial, a specific dose of astaxanthin helped preserve measured visual acuity after sustained screen use, in people 40 and older. It does not support "astaxanthin improves eyesight," "astaxanthin prevents age-related vision loss," or any claim touching macular degeneration, cataracts, glaucoma, or diabetic retinopathy — none of those conditions were studied here. The combination trial (Kizawa 2021) adds a second positive signal on pupillary and focusing measures, but because astaxanthin was combined with anthocyanin and lutein — two other compounds with their own eye-health evidence bases — it cannot tell you what astaxanthin alone contributed to that result.
Why the age split matters
The most clinically interesting — and most easily overstated — detail in Sekikawa 2023 is that the benefit showed up only in the 40-and-older subgroup, with no effect in younger participants. That's a real, disclosed result, not noise the researchers buried: it's consistent with the idea that natural lens and accommodation changes with age might make an antioxidant intervention more relevant later in life. But it's a subgroup finding within one trial, not an independently confirmed age threshold, so treat "helps eye fatigue after 40" as the honest, narrow version of this claim — not "helps everyone's eye fatigue."
If you're taking it for screen fatigue
If you want to try astaxanthin for screen-related eye fatigue with realistic expectations, 9 mg/day is the dose with direct trial support for this specific use (see the dosage guide) — there's no evidence a higher dose does more for this outcome. Astaxanthin is fat-soluble, so take it with a meal containing some fat. Pair realistic expectations with the basics that reliably help screen-related eye strain regardless of supplements: the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds), blinking more deliberately, and adjusting screen brightness/distance. If you have persistent eye pain, vision changes, or symptoms of a diagnosed eye condition, see an eye-care professional rather than relying on a supplement.
Frequently asked questions
Does astaxanthin help with eye strain from screens?
Modest, real evidence: 9 mg/day for 6 weeks preserved visual acuity after screen work in the ≥40y subgroup (Sekikawa 2023); a combination formula improved pupillary/focusing measures (Kizawa 2021). Both small, both industry-funded.
Does astaxanthin treat macular degeneration or cataracts?
No. These trials measured visual fatigue in healthy adults, not eye disease. Astaxanthin is not an approved or evidence-supported treatment for any eye disease.
Why did the trial only work in people over 40?
Sekikawa 2023 found the effect only in the ≥40y subgroup, with no mechanism confirmed. A real but unreplicated subgroup finding — not a universal effect.
Is this evidence trustworthy given the industry funding?
Industry funding is a real, disclosed limitation on both trials. Neither has been independently replicated by an unaffiliated group. Real signal, not settled proof.
Related
- Astaxanthin: what it is & who it's for
- Astaxanthin dosage guide — the 9 mg eye-fatigue dose in context
- Best astaxanthin — ranked by cost per mg
- Natural vs synthetic astaxanthin — does the source matter?
Sources
- Sekikawa T, et al. "Effects of astaxanthin from Haematococcus pluvialis on visual acuity after visual display terminal work." J Clin Biochem Nutr. 2023. PMID: 36777084
- Kizawa Y, et al. "Effects of anthocyanin, astaxanthin, and lutein supplementation on visual function." J Clin Biochem Nutr. 2021. PMID: 34376917